Global Injectable Drug Delivery Systems Market Research Report 2023

Publication ID:

PB501238726

Publication Date:

January 24, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.
Highlights
The global Injectable Drug Delivery Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Injectable Drug Delivery Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Injectable Drug Delivery Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Injectable Drug Delivery Systems include Baxter, Becton, Dickinson, Gerresheimer, Pfizer, Schott, ELI Lilly, Novartis, Terumo and Teva Pharmaceutical, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Systems.
The Injectable Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Injectable Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
Novo Nordik
Segment by Type
Pre-filled Syringes
Auto-injectors (Syringe and Cartridge Based)
Pen Injectors
Others
Segment by Application
Hospitals & Clinics
Home Care
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Injectable Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Injectable Drug Delivery Systems
1.2 Injectable Drug Delivery Systems Segment by Type
1.2.1 Global Injectable Drug Delivery Systems Market Value Comparison by Type (2023-2029)
1.2.2 Pre-filled Syringes
1.2.3 Auto-injectors (Syringe and Cartridge Based)
1.2.4 Pen Injectors
1.2.5 Others
1.3 Injectable Drug Delivery Systems Segment by Application
1.3.1 Global Injectable Drug Delivery Systems Market Value by Application: (2023-2029)
1.3.2 Hospitals & Clinics
1.3.3 Home Care
1.3.4 Others
1.4 Global Injectable Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Injectable Drug Delivery Systems Revenue 2018-2029
1.4.2 Global Injectable Drug Delivery Systems Sales 2018-2029
1.4.3 Global Injectable Drug Delivery Systems Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Injectable Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Injectable Drug Delivery Systems Sales Market Share by Manufacturers (2018-2023)
2.2 Global Injectable Drug Delivery Systems Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Injectable Drug Delivery Systems Average Price by Manufacturers (2018-2023)
2.4 Global Injectable Drug Delivery Systems Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Injectable Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Drug Delivery Systems, Product Type & Application
2.7 Injectable Drug Delivery Systems Market Competitive Situation and Trends
2.7.1 Injectable Drug Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable Drug Delivery Systems Players Market Share by Revenue
2.7.3 Global Injectable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Injectable Drug Delivery Systems Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Injectable Drug Delivery Systems Global Injectable Drug Delivery Systems Sales by Region: 2018-2029
3.2.1 Global Injectable Drug Delivery Systems Sales by Region: 2018-2023
3.2.2 Global Injectable Drug Delivery Systems Sales by Region: 2024-2029
3.3 Global Injectable Drug Delivery Systems Global Injectable Drug Delivery Systems Revenue by Region: 2018-2029
3.3.1 Global Injectable Drug Delivery Systems Revenue by Region: 2018-2023
3.3.2 Global Injectable Drug Delivery Systems Revenue by Region: 2024-2029
3.4 North America Injectable Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Injectable Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Injectable Drug Delivery Systems Sales by Country (2018-2029)
3.4.3 North America Injectable Drug Delivery Systems Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injectable Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Injectable Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Injectable Drug Delivery Systems Sales by Country (2018-2029)
3.5.3 Europe Injectable Drug Delivery Systems Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Injectable Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Injectable Drug Delivery Systems Sales by Country (2018-2029)
3.6.3 Asia Pacific Injectable Drug Delivery Systems Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injectable Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Injectable Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Injectable Drug Delivery Systems Sales by Country (2018-2029)
3.7.3 Latin America Injectable Drug Delivery Systems Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Injectable Drug Delivery Systems Sales by Country (2018-2029)
3.8.3 Middle East and Africa Injectable Drug Delivery Systems Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injectable Drug Delivery Systems Sales by Type (2018-2029)
4.1.1 Global Injectable Drug Delivery Systems Sales by Type (2018-2023)
4.1.2 Global Injectable Drug Delivery Systems Sales by Type (2024-2029)
4.1.3 Global Injectable Drug Delivery Systems Sales Market Share by Type (2018-2029)
4.2 Global Injectable Drug Delivery Systems Revenue by Type (2018-2029)
4.2.1 Global Injectable Drug Delivery Systems Revenue by Type (2018-2023)
4.2.2 Global Injectable Drug Delivery Systems Revenue by Type (2024-2029)
4.2.3 Global Injectable Drug Delivery Systems Revenue Market Share by Type (2018-2029)
4.3 Global Injectable Drug Delivery Systems Price by Type (2018-2029)
5 Segment by Application
5.1 Global Injectable Drug Delivery Systems Sales by Application (2018-2029)
5.1.1 Global Injectable Drug Delivery Systems Sales by Application (2018-2023)
5.1.2 Global Injectable Drug Delivery Systems Sales by Application (2024-2029)
5.1.3 Global Injectable Drug Delivery Systems Sales Market Share by Application (2018-2029)
5.2 Global Injectable Drug Delivery Systems Revenue by Application (2018-2029)
5.2.1 Global Injectable Drug Delivery Systems Revenue by Application (2018-2023)
5.2.2 Global Injectable Drug Delivery Systems Revenue by Application (2024-2029)
5.2.3 Global Injectable Drug Delivery Systems Revenue Market Share by Application (2018-2029)
5.3 Global Injectable Drug Delivery Systems Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Baxter Injectable Drug Delivery Systems Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Becton, Dickinson
6.2.1 Becton, Dickinson Corporation Information
6.2.2 Becton, Dickinson Description and Business Overview
6.2.3 Becton, Dickinson Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Becton, Dickinson Injectable Drug Delivery Systems Product Portfolio
6.2.5 Becton, Dickinson Recent Developments/Updates
6.3 Gerresheimer
6.3.1 Gerresheimer Corporation Information
6.3.2 Gerresheimer Description and Business Overview
6.3.3 Gerresheimer Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Gerresheimer Injectable Drug Delivery Systems Product Portfolio
6.3.5 Gerresheimer Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Injectable Drug Delivery Systems Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Schott
6.5.1 Schott Corporation Information
6.5.2 Schott Description and Business Overview
6.5.3 Schott Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Schott Injectable Drug Delivery Systems Product Portfolio
6.5.5 Schott Recent Developments/Updates
6.6 ELI Lilly
6.6.1 ELI Lilly Corporation Information
6.6.2 ELI Lilly Description and Business Overview
6.6.3 ELI Lilly Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.6.4 ELI Lilly Injectable Drug Delivery Systems Product Portfolio
6.6.5 ELI Lilly Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis Injectable Drug Delivery Systems Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Corporation Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Terumo Injectable Drug Delivery Systems Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Corporation Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Teva Pharmaceutical Injectable Drug Delivery Systems Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Novo Nordik
6.10.1 Novo Nordik Corporation Information
6.10.2 Novo Nordik Description and Business Overview
6.10.3 Novo Nordik Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Novo Nordik Injectable Drug Delivery Systems Product Portfolio
6.10.5 Novo Nordik Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Drug Delivery Systems Industry Chain Analysis
7.2 Injectable Drug Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Drug Delivery Systems Production Mode & Process
7.4 Injectable Drug Delivery Systems Sales and Marketing
7.4.1 Injectable Drug Delivery Systems Sales Channels
7.4.2 Injectable Drug Delivery Systems Distributors
7.5 Injectable Drug Delivery Systems Customers
8 Injectable Drug Delivery Systems Market Dynamics
8.1 Injectable Drug Delivery Systems Industry Trends
8.2 Injectable Drug Delivery Systems Market Drivers
8.3 Injectable Drug Delivery Systems Market Challenges
8.4 Injectable Drug Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
Novo Nordik

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂